SEC Form 4 · accession 0001615774-18-009357
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adeoye Y Olukotun
Director
Period of report
Sep 5, 2018
Accepted (ET)
Sep 7, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $1.03 | Sep 5, 2018 | A | 15,000 | A | — | Sep 5, 2028 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option was granted on September 5, 2018 pursuant to the Issuer's 2018 Equity Incentive Plan and vests on the date of the Issuer's 2019 annual meeting of shareholders.